Dividend Declaration

By

Regulatory News | 21 May, 2020

Updated : 17:20

RNS Number : 6799N
Triple Point VCT 2011 PLC
21 May 2020
 

21 May 2020

 

Triple Point VCT 2011 plc

(the "Company")

DIVIDEND DECLARATION

The Board of Triple Point VCT 2011 plc has today resolved to pay the following interim dividends:

·      6.75p per share to A Ordinary Class Shareholders (A Class Dividend)

·      5.00p per share to B Ordinary Class Shareholders (B Class Dividend)

·      3.00p per share to Venture Class Shareholders (Venture Dividend)

The A Class Dividend and B Class Dividend will be paid on 30 June 2020 to those A Ordinary Share Class and B Ordinary Share Class Shareholders on the register at the close of business on 12 June 2020. The ex-dividend dates for the A Class Dividend and B Class Dividend will be 11 June 2020.

The Venture Dividend will be paid on 31 July 2020 to those Venture Share Class Shareholders on the register at the close of business on 17 July 2020. The ex-dividend date for the Venture Dividend will be 16 July 2020.

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

 Triple Point Investment Management LLP

 (Investment Manager)

Tel: 020 7201 8989

 Ben Beaton

 Belinda Thomas

 Harry Penberthy

 

 

The Company's LEI is 213800AOOAQA5XQDEA89

 

Further information on the Company can be found on its website https://www.triplepoint.co.uk/current-vcts/triple-point-vct-2011-plc/s2539/.

 

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010. The Investment Manager is Triple Point Investment Management LLP. The Company was established to fund small and medium sized enterprises (SMEs). The Company launched a new share class, known as The Venture Fund, in March 2019 which is mandated to invest in SMEs producing products or digital services that solve challenges faced by their larger corporate customers.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVABMFTMTBTBRM

Last news